An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Activation of inflammasome signaling can produce harmful inflammation. In this issue of Immunity, Yan et al. (2013) suggest that omega-3 fatty acids commonly found in marine oils can suppress activation of NLRP3 and NLRP1b inflammasomes.
Figure 1. Activation and inhibition of NLRP3 inflammasome signaling
Activation of the NLRP3 inflammasome is…
Figure 1. Activation and inhibition of NLRP3 inflammasome signaling
Activation of the NLRP3 inflammasome is a two-signal process. “Signal 1” occurs by stimulation of toll-like receptors (TLRs) by microbial or endogenous ligands leading to NF-κB-dependent upregulation of the pro-IL-1β. “Signal 2” is provided by a wide array of NLRP3 inflammasome activators such as nigericin, anthrax lethal toxin, β-amyloid, islet amyloid polypeptide and cholesterol and monosodium irate crystals (not shown). Activated NLRP3 binds to pro-caspase-1 via the adaptor protein ASC, leading to caspase-1 cleavage of pro- IL-1β and IL-18. Yan et al. (2013) show that the mechanism for ω-3FA inhibition of NLRP3-mediated inflammation involves ω-3FAs interacting with the GPR120 and GPR40 receptors. Subsequently, the downstream scaffold protein ARRB-2 binds to GPR120 and GPR40 and the complex is internalized. There are reports that this pathway inhibits “signal 1” at the level of TAB1 and TAK1 kinases to inhibit NF-κB (Glass and Olefsky, 2012). Yan et al. (2013) also demonstrate here how “signal 2” is inhibited when ARRB-2 directly associates with NLRP3 leading to inhibition of pro-inflammatory cytokine release, and inhibition of inflammation.
Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C, Guarda G, Tian Z, Tschopp J, Zhou R.Yan Y, et al.Immunity. 2013 Jun 27;38(6):1154-63. doi: 10.1016/j.immuni.2013.05.015.Immunity. 2013.PMID: 23809162
References
Anderson M, Fritsche KL. (n-3) Fatty acids and infectious disease resistance. J Nutr. 2002;132:3566–3576.
-
PubMed
Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011;29:707–735.
-
PMC
-
PubMed
Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464:1357–1361.
-
PMC
-
PubMed
Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15:635–645.
-
PMC
-
PubMed
Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482:179–185.
-
PMC
-
PubMed